Ex-No­var­tis busi­ness head hops over to a gene ther­a­py start­up — and she's reeled in $80M for a dash to the clin­ic

Neu­rol­o­gist and King’s Col­lege Lon­don pro­fes­sor Christo­pher Shaw has been re­search­ing neu­rode­gen­er­a­tive dis­eases like ALS and col­lab­o­rat­ing with drug­mak­ers for the last 25 years in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER